By integrating autonomous AI agents into record-to-report workflows, Genpact aims to strip away the manual friction that stalls corporate finance teams. The new suite promises to resolve nearly all intercompany discrepancies in real time, shifting the burden of reconciliation from human accountants to self-learning digital systems.
Australian healthcare practitioners gained access to the new Fraxel FTX skin resurfacing platform on September 1, 2026. Designed by Bausch Health’s aesthetics subsidiary, Solta Medical, the system aims to enhance treatment precision and patient comfort while building on the clinical heritage of its predecessor.
Finlays Solutions has appointed Kristin Bird and Trevor Bynum as Independent Non-Executive Directors, signaling a strategic push to accelerate growth within the competitive food service sector. The pair joins founding director Jennifer Aspen Mason to provide high-level counsel as the company integrates its expanded North American manufacturing footprint.
Four Polaris off-road vehicles and a suite of digital unlocks are fueling a new promotional campaign between Monster Energy and Call of Duty: Modern Warfare 4. Starting September 1, players can redeem codes found on cans to earn exclusive in-game content ahead of the game's October 23 release.
After nearly three decades at Paycor, Jay Rouse has joined Cincinnati-based ConstructConnect as Executive Vice President and Chief Revenue Officer. Tasked with overseeing the firm's sales and customer success divisions, Rouse arrives as the company intensifies its integration of AI-driven tools into the preconstruction workflow.
With 95% of winning vendors appearing on a buyer’s day-one shortlist, the real sales battle is often won months before a formal conversation begins. For companies navigating 10-month buying cycles, the challenge lies in maintaining visibility while prospects are still researching and not yet ready to purchase.
As major cloud operators prepare to sink $1.2 trillion into artificial intelligence infrastructure by 2027, investors are increasingly mistaking capital expenditure for economic gain. New Constructs warns that while hardware and compute capacity are necessary inputs for AI, they do not inherently guarantee pricing power or sustainable returns.
Vancouver-based Conexiom has unveiled Relay, an automation platform designed to process unstructured order and invoice data while offering full transparency into AI decision-making. By moving away from opaque models, the system allows manufacturers and distributors to verify automated workflows against their own institutional knowledge and business rules.
Copenhagen-based Configit has signed a strategic partnership with NxRev to integrate its Configuration Lifecycle Management technology with NxRev’s established engineering software services. The collaboration aims to bridge the gap between engineering design data and downstream manufacturing, sales, and service processes for discrete manufacturers across the United States.
Surgical Directions has named Carilion Clinic its 2025 Client of the Year, citing the Roanoke-based health system’s success in building a sustainable, physician-led perioperative framework. The recognition highlights how the organization unified surgeons, anesthesiologists, and nursing leadership to drive measurable gains in operational efficiency and patient access.
Rising prescription drug spending is cannibalizing corporate budgets, forcing a choice between rising premiums or reduced investment in staff. Paul Pruitt, co-founder of SHARx, argues that employers must stop treating pharmacy benefits as a narrow procurement task and start measuring their true impact on retention, hiring, and employee trust.
The National Bank of Yemen is implementing a comprehensive financial integrity training program for its 950 employees across 25 branches. This initiative targets the modernization of cross-border payment standards and risk management, positioning the state-owned institution to better navigate the complexities of the international financial system and trade compliance.
A new study published in Reproductive BioMedicine Online confirms 96% agreement between Mira’s at-home hormone monitoring and professional transvaginal ultrasound scans. The research, which tracked 121 ovulatory cycles, validates quantitative urine testing as a reliable, non-invasive alternative to traditional clinical diagnostics for reproductive health and fertility tracking.
Farragut Square is trading office bustle for barre classes and live music as the Golden Triangle Business Improvement District launches its seasonal outdoor series. Beginning September 8, the downtown park will host a rotating roster of wellness sessions and lunchtime performances aimed at drawing residents and workers back into the city center.
Starting January 1, 2030, the National Certification Corporation will require all applicants for Neonatal and Women’s Health Care Nurse Practitioner certifications to complete 750 hours of direct patient care. This shift aims to align certification standards with current national educational benchmarks and recent regulatory updates.
Seventy percent of U.S. skincare users now prioritize barrier protection, driving a shift toward restorative treatments. Responding to this demand, Allergan Aesthetics has launched the Barrier Calming Cream, a new addition to the SkinMedica portfolio designed to fortify the skin's moisture layer and improve overall resilience.
A custom-built freezer compartment in the 2026 Toyota Sienna has inspired a new partnership between the automaker and Cincinnati-based Graeter’s Ice Cream. The collaboration introduces limited-edition Salted Caramel Chip Wheels, a dessert designed to be stored within the vehicle's integrated console cooler while families are on the road.
“The Cranberry Wealth Retirement Show is about bringing clarity, energy, and honest conversation to the financial topics that matter most,” says Kelton Burgess, founder of Cranberry Wealth Management. Starting August 17, the Pittsburgh-based advisor will host a weekly hour-long program on KDKA AM 1020 dedicated to dismantling conventional financial guidance.
As enterprises deploy AI agents capable of executing code at machine speed, a new layer of security has become critical to prevent rogue operations. Sevii is addressing this shift by launching an AI Security module designed to transform runtime detections into autonomous, end-to-end cyber defense outcomes without human intervention.
A panel of Harvard academics, medical specialists, and corporate leaders will gather at Harvard Business School on October 15 to award $1 million to AI-driven health solutions. The WellWithAll Prize seeks to scale existing technologies that address persistent gaps in healthcare access for underserved American communities.
A new preclinical study from Sydney-based Kazia Therapeutics indicates that its lead asset, paxalisib, can successfully reprogram immunotherapy-resistant colorectal tumors. The drug reduced tumor burden by 52% in laboratory models of microsatellite stable cancer, offering a potential breakthrough for a patient population that historically lacks effective treatment options.
With an estimated 13 million Americans affected by Dupuytren’s contracture, Keenova Therapeutics is marking the second annual National Hand Health Month this September by introducing a new mixed-reality educational program designed to help healthcare professionals visualize the condition and improve patient diagnostic outcomes.
Keurig Dr Pepper is offloading its minority stake in Chobani and a manufacturing facility in Allentown, Pennsylvania, in a $925 million deal. The move serves a dual purpose: providing a significant cash injection to reduce the beverage giant's debt while deepening a commercial distribution partnership between the two companies.
One in every 50 Americans currently lives with an unruptured brain aneurysm, a statistic driving the Brain Aneurysm Foundation’s push for expanded clinical research this September. As the organization marks National Brain Aneurysm Awareness Month, it has committed a record $650,000 to support 18 diverse medical projects.
Chobani is launching a major expansion in Allentown, Pennsylvania, committing $1.2 billion over five years to transform a 1.5-million-square-foot manufacturing site into a cornerstone of its national growth strategy. The project aims to create 900 jobs while significantly scaling the company's production of high-protein dairy products.
Northstar Clean Technologies has officially cleared its fourth production milestone with Emissions Reduction Alberta, marking a pivotal step in the commercial ramp-up of its Calgary facility. Despite achieving processing rates as high as 160 tonnes per day, the company has temporarily paused operations to finalize critical system upgrades.
Lexus is pivoting its popular NX compact crossover to a fully electrified lineup for the 2027 model year, offering exclusively hybrid and plug-in hybrid powertrains. The refreshed vehicle, slated for global release by late 2026, pairs enhanced structural rigidity and refined driving dynamics with a standardized 14-inch touchscreen interface across all grades.
Private investment firm GI Partners has acquired a majority interest in Montreal-based Otodata, a specialist in remote tank monitoring and vehicle tracking. The deal marks a transition in ownership for the company, which maintains an installed base of over 3.5 million monitored units across global markets.
A new preclinical study published in the journal Biomolecules suggests that the polyphenol-enriched ingredient Elissara may go beyond scalp health to actively support hair follicle function. Researchers found the botanical blend helps preserve critical growth-signaling proteins even when follicles are subjected to environmental stressors like pollution and UV radiation.
Following preclinical success in resensitizing treatment-resistant tumors, Kazia Therapeutics is expanding its clinical trials into HR+/HER2- breast cancer. The company aims to address a significant medical gap by combining its lead asset, paxalisib, with standard-of-care therapies to overcome resistance mechanisms driven by PI3K/mTOR pathways.
